Abbvie Inc. vs Zoetis Inc.
ABBV vs ZTS — side-by-side comparison from reported financials. ABBV leads 4, ZTS leads 7 of 11 comparable metrics.
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
Zoetis Inc.
ZTS · Healthcare
$73.90+1.12%Mixed
| Metric | ABBV | ZTS |
|---|---|---|
| Price | $276.43 | $73.90 |
| Market cap | $488B | $30.5B |
| Revenue (TTM) | $64.4B | $9.52B |
| Revenue growth | +1.8% | +5.4% |
| Net margin | 9.8% | 27.5% |
| Free cash flow | $18.2B | $2.37B |
| Net cash (debt) | ($56.2B) | ($6.73B) |
| 1-year price return | +19.8% | -48.5% |
| P/E | 77.4 | 11.8 |
| P/E vs own history (cheap-side %) | 23% | 97% |
| Dividend yield | 2.45% | 2.89% |
| Return on equity | 96% | 69% |
| Altman Z-score | 2.33 | — |
| CV checks passed | 9 of 11 | 10 of 11 |
| Employees | 57,000 | 14,500 |
Full résumé-style profiles: ABBV CV · ZTS CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.